FineMark National Bank & Trust’s Abiomed Inc ABMD Stock Holding History

FineMark National Bank & Trust’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-23	Closed	-$3K	–	1069
2016 Q4	$3K	Sell	23 -3	-12%	-$348	﹤0.01%	1136
2016 Q3	$3K	Hold	26	–	–	﹤0.01%	1140
2016 Q2	$3K	Sell	26 -4	-13%	-$398	﹤0.01%	1166
2016 Q1	$3K	Hold	30	–	–	﹤0.01%	1105
2015 Q4	$3K	Hold	30	–	–	﹤0.01%	1126
2015 Q3	$3K	Sell	30 -5	-14%	-$441	﹤0.01%	1201
2015 Q2	$2K	Buy	+35	New	+$2.33K	﹤0.01%	1293

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FineMark National Bank & Trust's ABMD Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Abiomed Inc (ABMD) in Q1 2017, closing a stake of 23 shares — an estimated $3K sold.

FineMark National Bank & Trust first reported a position in ABMD in Q2 2015 and held it in 7 quarters. The position peaked at $3K in Q4 2016. 287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

FineMark National Bank & Trust reported no remaining Abiomed Inc position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 23 Abiomed Inc shares in Q1 2017, an estimated $3K.
FineMark National Bank & Trust first reported a position in Abiomed Inc in Q2 2015 and held it in 7 quarters.
FineMark National Bank & Trust's Abiomed Inc position peaked at $3K in Q4 2016.
287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.